• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

AstraZeneca PLC (AZN)

American Depository Receipt
Sell: $69.52|Buy: $70.00|Change: 1.04 (1.52%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Address

2 Kingdom Street
London
GBR
W2 6BD

Telephone

+44 2076048000

Website

https://www.astrazeneca.com

Sector 

Healthcare

Forecast key dates

NameKey Date
AstraZeneca PLC First Quarter Earnings Results for 20262026-04-29T00:00:00
AstraZeneca PLC First Quarter Earnings Conference Call for 20262026-04-29T00:00:00
AstraZeneca PLC Annual General Meeting for 20262026-04-10T00:00:00
AstraZeneca PLC Annual Report for 20252026-02-18T00:00:00
AstraZeneca PLC Fourth Quarter Earnings Result for 20252026-02-06T00:00:00
AstraZeneca PLC Fourth Quarter Earnings Conference Call for 20252026-02-06T00:00:00
AstraZeneca PLC Third Quarter Earnings Conference Call for 20252025-11-12T14:00:00
AstraZeneca PLC Third Quarter Earnings Results for 20252025-11-12T00:00:00
AstraZeneca PLC Second Quarter Earnings Conference Call for 20252025-07-25T11:45:00
AstraZeneca PLC Second Quarter Earnings Results for 20252025-07-25T00:00:00
AstraZeneca PLC First Quarter Earnings Result for 20252025-04-29T00:00:00
AstraZeneca PLC First Quarter Earnings Conference Call for 20252025-04-29T00:00:00
AstraZeneca PLC Annual General Meeting for 20252025-04-11T00:00:00

Previous key dates

NameKey Date
AstraZeneca PLC First Quarter Earnings Result for 20252025-04-29T00:00:00
AstraZeneca PLC First Quarter Earnings Conference Call for 20252025-04-29T00:00:00
AstraZeneca PLC Annual General Meeting for 20252025-04-11T00:00:00
AstraZeneca PLC Annual Report for 20242025-02-18T00:00:00
AstraZeneca PLC Fourth Quarter Earnings Conference Call for 20242025-02-06T11:00:00
AstraZeneca PLC Fourth Quarter Earnings Results for 20242025-02-06T07:00:00
AstraZeneca PLC Third Quarter Earnings Conference Call for 20242024-11-12T14:00:00
AstraZeneca PLC Third Quarter Earnings Result for 20242024-11-12T00:00:00
Depositary Receipts Virtual Investor Conference2024-09-24T11:30:00
AstraZeneca PLC Second Quarter Earnings Conference Call for 20242024-07-25T11:45:00
AstraZeneca PLC Second Quarter Earnings Result for 20242024-07-25T00:00:00
AstraZeneca PLC First Quarter Earnings Conference Call for 20242024-04-25T11:45:00
AstraZeneca PLC First Quarter Earnings Result for 20242024-04-25T00:00:00
AstraZeneca PLC Annual General Meeting for 20242024-04-11T14:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.